// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Development of Paediatric Musculoskeletal Matters Nursing (PMM-Nursing): a free online evidence based education e-resource for nurses

Nicola Smith - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Methadone hydrochloride

Highly elevated ferritin levels are associated with haemophagocytic lymphohistiocytosis/macrophage activation syndrome: are we missing treatable diagnoses? A retrospective service evaluation of diagnosis in patients with ferritin >10,000 microgram/L

Ethan S Sen - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Hemophagocytic lymphohistiocytosis

Interleukin

Searching for a prodrome for rheumatoid arthritis in the primary care record: a clinical practice research datalink study

Sara Muller - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Paediatric musculoskeletal (MSK) triage in the community: Rightpath a pilot study

Nicola Smith - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Multimorbidity is associated with increased disability but lower disease activity over time in patients with RA: results from the BSRBR-RA

Jenny Humphreys - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Factors associated with disability in rheumatoid arthritis patients with persistent moderate disease activity

Ian C Scott - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Summary of baricitinib effect on patient-reported outcomes (PROs) in methotrexate-inadequate responder patient population

Maxime Dougados - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Methotrexate

Glucocorticoid-associated adrenal insufficiency in patients with rheumatoid arthritis: a study combining direct data collection with electronic health records

Rebecca M Joseph - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Addison's disease

Glucocorticoid

The impact of the EIA clinic on early RA care

Mark Yates - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Clinical outcomes of a multi-disciplinary switching programme to biosimilar etanercept for patients with rheumatoid arthritis

Kavina Shah - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Etanercept

Serum osteopontin levels are associated with the subclinical cardiovascular disease in patients with rheumatoid arthritis

Sarah Skeoch - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Coronary Artery Disease

N/A

Monitoring of interstitial lung disease in rheumatoid patients in routine clinical practice and therapies

Shehla Siddiqui - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Interstitial lung disease

N/A

Prevalence of impaired health literacy in patients with rheumatoid arthritis and its association with medication understanding and patient outcomes

Ellen Grose-Hodge - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Rheumatoid arthritis

N/A

Implementation of a reduced rituximab maintenance regimen for patients with rheumatoid arthritis

Catherine M McGrath - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Rituximab

Genome-wide association study of response to tumour necrosis factor inhibitor therapy in rheumatoid arthritis

Jonathan Massey - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

The effect of JAK inhibition on neutrophil killing, netosis and metabolism in rheumatoid arthritis

Susama Chokesuwattanaskul - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Baricitinib

The validation of salivary C-reactive protein as a marker of inflammation in humans

Matthew Smith - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Testing the water: management of rheumatological conditions by non-rheumatology trainees

Naveen Bhadauria - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The service user satisfaction and uptake of the North Bristol NHS Trust fast track physiotherapy service after six months

Alice Clevely - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Pilot of a rheumatology extended scope practitioner to improve the triage process andassess patients with non-inflammatory conditions

Sarah J Fish - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved